Presented by: Dr Tim Raine (Consultant Gastroenterologist, Cambridge University Hospitals)
Learning Objectives
Emerging biologic and small molecule therapies for Crohn’s disease.
Emerging biologic and small molecule therapies for ulcerative colitis.
Safety of these emerging treatments.
The gastrointestinal microbiome.
Future treatment for inflammatory bowel disease.
Considerations when co-managing patients with inflammatory bowel disease, arthritis, skin and/or eye disease.
